Abstract: The use of carboxylate ligand modified ferric iron hydroxide compositions for the treatment or prevention of iron deficiency associated with liver diseases is disclosed, and more particularly to the class of Iron Hydroxide Adipate Tartrate (IHAT) materials for 10 use in the treatment or prevention of iron deficiency associated with non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH).
Type:
Grant
Filed:
April 1, 2021
Date of Patent:
June 17, 2025
Assignee:
Nemysis Ltd.
Inventors:
Danilo Casadei Massari, Maria Cristina Comelli, Jonathan Powell, Nuno Faria, Katharina Kessler
Abstract: The use of carboxylate ligand modified ferric iron hydroxide compositions for the treatment or prevention of iron deficiency associated with liver diseases is disclosed, and more particularly to the class of Iron Hydroxide Adipate Tartrate (IHAT) materials for 10 use in the treatment or prevention of iron deficiency associated with non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH).
Type:
Application
Filed:
April 1, 2021
Publication date:
May 4, 2023
Applicant:
Nemysis Ltd.
Inventors:
Danilo Casadei Massari, Maria Cristina Comelli, Jonathan Powell, Nuno Faria, Katharina Kessler